- Home
- BNR vs UONEK Comparison
BNR vs UONEK Comparison
Compare BNR & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- UONEK
- Stock Information
- Founded
- BNR 2014
- UONEK 1980
- Country
- BNR China
- UONEK United States
- Employees
- BNR N/A
- UONEK N/A
- Industry
- BNR Medical Specialities
- UONEK Broadcasting
- Sector
- BNR Health Care
- UONEK Consumer Discretionary
- Exchange
- BNR Nasdaq
- UONEK Nasdaq
- Market Cap
- BNR 38.3M
- UONEK 31.4M
- IPO Year
- BNR 2020
- UONEK N/A
- Fundamental
- Price
- BNR $12.25
- UONEK $0.47
- Analyst Decision
- BNR
- UONEK
- Analyst Count
- BNR 0
- UONEK 0
- Target Price
- BNR N/A
- UONEK N/A
- AVG Volume (30 Days)
- BNR 33.9K
- UONEK 30.2K
- Earning Date
- BNR 12-02-2025
- UONEK 11-04-2025
- Dividend Yield
- BNR N/A
- UONEK N/A
- EPS Growth
- BNR N/A
- UONEK N/A
- EPS
- BNR N/A
- UONEK N/A
- Revenue
- BNR $74,862,782.00
- UONEK $393,670,000.00
- Revenue This Year
- BNR $136.32
- UONEK N/A
- Revenue Next Year
- BNR N/A
- UONEK N/A
- P/E Ratio
- BNR N/A
- UONEK N/A
- Revenue Growth
- BNR 5.20
- UONEK N/A
- 52 Week Low
- BNR $2.18
- UONEK $0.44
- 52 Week High
- BNR $13.89
- UONEK $1.40
- Technical
- Relative Strength Index (RSI)
- BNR 60.87
- UONEK 31.95
- Support Level
- BNR $11.31
- UONEK $0.45
- Resistance Level
- BNR $12.71
- UONEK $0.62
- Average True Range (ATR)
- BNR 1.04
- UONEK 0.05
- MACD
- BNR 0.09
- UONEK -0.01
- Stochastic Oscillator
- BNR 72.11
- UONEK 26.39
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.